Effect of Artificial Intelligence-Assisted Motivational Talk on Patients' Fear of Movement and Mobility Level After Knee Replacement
Launched by KOCAELI UNIVERSITY · Dec 26, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a motivational talk, created with the help of artificial intelligence, can help patients feel less afraid of moving after knee replacement surgery. Many people experience fear about moving after their surgery, which can slow down their recovery and make it harder for them to walk and be active. This trial aims to see if using an AI-designed motivational speech can reduce this fear, improve mobility, and support patients in their recovery.
To participate in this trial, you must be at least 18 years old and have had knee replacement surgery. It's also important that you can understand and speak Turkish, as well as read and write. Unfortunately, if you have certain conditions—like ongoing pain, mental health issues, or hearing and visual impairments—you may not be eligible to join. If you decide to participate, you can expect to listen to the motivational talk and share your experiences, helping researchers understand how this approach can improve recovery for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient must have had knee replacement surgery,
- • Be over 18 years of age,
- • Agree to participate in the study,
- • Be able to understand and speak Turkish,
- • Be able to read and write
- Exclusion Criteria:
- • Cancellation or postponement of patient's surgery
- • Patients in pain,
- • Those whose walking is not recommended by the physician,
- • Those with mental disabilities or psychological disorders,
- • Patients who are alcohol or drug addicts,
- • Those with hearing or visual impairments,
- • Patients who do not want to use the headphones that will be used in the study.
About Kocaeli University
Kocaeli University, a prominent institution in Turkey, is dedicated to advancing medical research and education through its comprehensive clinical trial initiatives. With a focus on innovative healthcare solutions, the university collaborates with leading researchers and healthcare professionals to conduct rigorous scientific studies aimed at improving patient outcomes. By fostering an environment of academic excellence and interdisciplinary collaboration, Kocaeli University aims to contribute significantly to the global medical community while ensuring adherence to ethical standards and regulatory guidelines in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported